How can PrEP use among Black people be improved?
https://fed.brid.gy/r/https://www.advocate.com/health/sexual-health/black-people-and-hiv-prevention
How can PrEP use among Black people be improved?
https://fed.brid.gy/r/https://www.advocate.com/health/sexual-health/black-people-and-hiv-prevention
Referenced link: https://medicalxpress.com/news/2023-03-black-patients-hospitalized-die-pulmonary.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2023-03-black-patients-hospitalized-die-pulmonary.html
Originally posted by Phys.org / @physorg_com: http://nitter.platypush.tech/medical_xpress/status/1634275196315095055#m
RT by @physorg_com: #Blackpatients are diagnosed with, hospitalized for and die of #pulmonaryfibrosis at younger ages than white patients @jamanetworkopen https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802255 https://medicalxpress.com/news/2023-03-black-patients-hospitalized-die-pulmonary.html
Pulmonary fibrosis is a devastating disease characterized by progressive scarring in the lungs, killing up to half of patients within five years of a diagnosis. Little is known about whether there are differences in how the condition affects individuals of different ethnicities.
Referenced link: https://medicalxpress.com/news/2022-10-black-patients-atrial-fibrillation-adverse.html
Discuss on https://discu.eu/q/https://medicalxpress.com/news/2022-10-black-patients-atrial-fibrillation-adverse.html
Originally posted by Phys.org / @[email protected]: https://twitter.com/medical_xpress/status/1585622355640025089#m
RT by @physorg_com: #Blackpatients with #atrialfibrillation more likely to experience adverse outcomes @JAMACardio https://jamanetwork.com/journals/jamacardiology/fullarticle/2797284 https://medicalxpress.com/news/2022-10-black-patients-atrial-fibrillation-adverse.html
Black patients with atrial fibrillation are less likely to be prescribed newer anticoagulant medications when they leave the hospital compared to their white counterparts and are consequently more likely to experience adverse outcomes, including stroke and death, according to a new study led by University of Pittsburgh School of Medicine physician-scientists and published today in JAMA Cardiology.